Precision Trials: Navigating the Complexity of Immuno-Oncology
Immuno-oncology (I-O) therapies represent one of the boldest frontiers in cancer treatment, but running I-O trials is inherently complex. These…
Insights
The Data-Driven Future: Why AI is the Agility Engine for Modern CROs
Moving beyond simple data collection. We explore how predictive analytics and machine learning are revolutionizing trial design, site selection, and patient recruitment, drastically cutting time-to-insight.
LATEST INSIGHTS
Latest Insights
The Speed Advantage: How to Cut Site Activation Time Without Sacrificing Quality
In clinical development, time lost is progress delayed. One of the largest bottlenecks in getting a trial underway is the…
More Than a Protocol: Designing Patient-Centric Trials for Rare Diseases
For sponsors working in the rare disease space, the challenge is immense. With small patient populations, geographically scattered individuals, and…
The Data-Driven Future: Why AI is the Agility Engine for Modern CROs
For too long, clinical research has been a game of chance—relying on historical data, slow manual processes, and educated guesses.…
Meet Our Expert Team
— Alex Rhee
VP, Clinical Operations
— Dr. Maya Sorrentino
Chief Scientific Officer
— Sara Patel
Director, Regulatory Affairs
— Dr. Kenji Watanabe
Head of Biostatistics
— Lisa Thornton
Director, Project Delivery